The effect on macular function of the wavelength of laser light used to treat proliferative diabetic retinopathy was studied. Panretinal laser photocoagulation is an established and effective treatment for proliferative diabetic retinopathy.' 2 Argon blue-green lasers have been used most commonly. There is, however, increasing awareness of the potential phototoxic hazards of short wavelength lasers both for the operator34 and for the patient.5 The aim of the present study was to determine by a battery ofmacular function tests, whether macular phototoxicity could be demonstrated after panretinal laser photocoagulation, as currently practised, and if so whether longer wavelengths produced less of an effect than others.
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